Pfizer seeking emergency use of its COVID-19 vaccine in US
Associated Press
1 / 5
FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer said Friday, Nov. 20, 2020, it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter. (AP Photo/Bebeto Matthews, File)FILE - In this Nov. 9, 2020, file photo, an ad for COVID-19 testing reflects on glass at a bus stop, as pedestrians walk past Pfizer world headquarters in New York. On Friday, Nov. 20, 2020, Pfizer has asked U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. (AP Photo/Bebeto Matthews, File)FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)This photo provided by Pfizer shows Pfizer's COVID-19 vaccine storage facility in Kalamazoo, Mich. Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. Friday, Nov. 20, step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. (Jerica Pitts/Pfizer via AP)This photo provided by Pfizer shows Pfizer's COVID-19 vaccine storage facility in Kalamazoo, Mich. Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. Friday, Nov. 20, step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. (Jerica Pitts/Pfizer via AP)
Copyright 2020 The Associated Press. All rights reserved.
FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer said Friday, Nov. 20, 2020, it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter. (AP Photo/Bebeto Matthews, File)